The neuromyelitis optica spectrum disorder market size in the 7MM is expected to show positive growth during the forecast period (2026-2036), mainly attributed to the increasing prevalence of ...
During a live event, Marc J. Braunstein, MD, PhD, and participants discussed maintenance lenalidomide and daratumumab as well as the clinical potential of MRD in multiple myeloma.
Recently published Neuromyelitis Optica Spectrum Disorder Market Insights report includes a comprehensive understanding of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results